Table 2.
Stage | Lugano System | Paris System | Tumor Extension |
---|---|---|---|
I | Tumor confined to GI tract (single, primary site or multiple, noncontiguous lesions) | T1m N0 M0 | Mucosa |
T1sm N0 M0 | Submucosa | ||
T2 N0 M0 | Muscularis propria | ||
T3 N0 M0 | Serosa | ||
II | Tumor extending into abdomen | NA | NA |
II1 | Local nodal involvement | T1–3 N1 M0 | Perigastric lymph nodes |
II2 | Distant nodal involvement | T1–3 N2 M0 | More distant regional lymph nodes |
IIE | Perforation of serosa to involve adjacent organs or tissues | T4 N0–2 M0 | Invasion of adjacent structures with or without invasion of abdominal lymph nodes |
IV | Disseminated extranodal involvement or concomitant supradiaphragmatic nodal involvement | T1–4 N3 M0 | Extra-abdominal lymph nodes |
T1–4 N0–3 M1 | and/or additional distant GI/non-GI sites | ||
T1–4 N0–3 M2 | BM not assessed | ||
T1–4 N0–3 M0–2 BX | BM not involved | ||
T1–4 N0–3 M2 B1 | BM involvement |
BM: bone marrow; GI: gastrointestinal; NA: not available.